Editorial: Targeting pumps, channels and transporters for the treatments of vascular, cardiovascular and kidney diseases

Jinwei Zhang; Keith Siew; Dandan Sun

doi:10.3389/fphar.2023.1130882

Editorial: Targeting pumps, channels and transporters for the treatments of vascular, cardiovascular and kidney diseases

Front Pharmacol. 2023 Feb 1:14:1130882. doi: 10.3389/fphar.2023.1130882. eCollection 2023.

Authors

Jinwei Zhang^{1

2

3}, Keith Siew⁴, Dandan Sun^{5

6}

Affiliations

¹ Institute of Cardiovascular Diseases, Xiamen Cardiovascular Hospital Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China.
² State Key Laboratory of Bioorganic & Natural Products Chemistry, Center for Excellence in Molecular Synthesis, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China.
³ Hatherly Laboratories, Institute of Biomedical and Clinical Sciences, Medical School, Faculty of Health and Life Sciences, University of Exeter, Exeter, United Kingdom.
⁴ Department of Renal Medicine, University College London, London, United Kingdom.
⁵ Department of Neurology, University of Pittsburgh, Pittsburgh, PA, United States.
⁶ Veterans Affairs Pittsburgh Healthcare System, Geriatric Research, Education, and Clinical Center, Pittsburgh, PA, United States.

No abstract available

Keywords: cardiovascular disease; ion channel; ion transporter; kidney disease; signal transduction; therapeutics; vascular disease.

Publication types

Editorial

Grants and funding

This work was supported by the National Natural Science Foundation of China grants 82170406, and 81970238 (JZ), The Royal Society UK grant IEC\NSFC\201094 (JZ), and department of Veterans Affairs grants I01BX002891, I01BX004625, and IK6BX005647 (DS).